Aurinia Pharmaceuticals
AUPH
#4839
Rank
C$2.60 B
Marketcap
C$19.78
Share price
-0.79%
Change (1 day)
72.32%
Change (1 year)

Market capitalization of Aurinia Pharmaceuticals (AUPH)

Market cap: C$2.60 Billion

As of February 2026 Aurinia Pharmaceuticals has a market cap of C$2.60 Billion. This makes Aurinia Pharmaceuticals the world's 4839th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aurinia Pharmaceuticals from 2009 to 2026

End of year Market Cap

Year Marketcap Change
2026C$2.60 B-11.1%
2025C$2.93 B55.22%
2024C$1.89 B10.39%
2023C$1.71 B105.55%
2022C$0.83 B-77.96%
2021C$3.77 B70.06%
2020C$2.22 B-24.38%
2019C$2.93 B270.33%
2018C$0.79 B64.98%
2017C$0.48 B329.22%
2016C$0.11 B-0.23%
2015C$0.11 B-14.91%
2014C$0.13 B172.18%
2013C$48.49 M357.38%
2012C$10.6 M-49.01%
2011C$20.79 M-48.72%
2010C$40.55 M86.25%
2009C$21.77 M

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Aurinia Pharmaceuticals was reported to be:

C$2.62 Billion
by Nasdaq info icon info icon
C$2.62 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
C$112.78 B 4,223.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
C$24.55 M-99.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
C$23.95 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA